Generic drug sponsors now can file an ANDA with facilities that are not ready for inspection, but the US Food and Drug Administration is not necessarily suggesting they should.
The new generic drug user fee agreement allows the agency to set a goal date for ANDAs that include facilities...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?